Regulation of the salvage pathway of deoxynucleotides synthesis in apoptosis induced by growth factor deprivation

被引:14
|
作者
Oliver, FJ
Collins, MKL
LopezRivas, A
机构
[1] CSIC,INST PARASITOL & BIOMED,E-18001 GRANADA,SPAIN
[2] CANC RES INST,CHESTER BAY LABS,LONDON SW3 6JB,ENGLAND
关键词
D O I
10.1042/bj3160421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Here we describe changes in dNTP metabolism that precede DNA fragmentation in a model of apoptosis driven by deprivation of the cytokine interleukin 3 (IL-3). In haemopoietic BAF3 cells, IL-3 withdrawal leads to a rapid decrease in the size of dATP, dTTP and dGTP pools without affecting dCTP levels. This imbalance in dNTP pools precedes DNA fragmentation and is accompanied by down-regulation of enzymes controlling the de novo and salvage pathways of dNTP synthesis, ribonucleotide reductase and thymidine kinase (TK) respectively. Readdition of IL-3 results in a rapid, protein synthesis-independent restoration of normal dNTP pools, enhanced TK activity and increased precursor incorporation through the salvage pathway. Up-regulation of TK activity after IL-3 readdition is prevented by the protein kinase C (PKC) inhibitor staurosporin, but not by tyrosine kinase inhibitors. Furthermore activation of PKC by phorbol esters mimics the stimulatory effect of IL-3 on TK activity, suggesting that PKC might be involved in regulating this effect. These results indicate that regulation by IL-3 of the salvage pathway of dNTP synthesis plays a role in the maintenance of cellular dNTP pool balance and suggests that alterations in dNTP metabolism after IL-3 deprivation could be a relevant event in the commitment of haemopoietic cells to apoptosis.
引用
收藏
页码:421 / 425
页数:5
相关论文
共 50 条
  • [1] Growth factor deprivation-induced endothelial apoptosis is dependent on the cell density
    Kinoshita, M
    Higaki, M
    Shimokado, K
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 243 - 243
  • [2] Effect of safrole oxide on vascular endothelial cell growth and apoptosis induced by deprivation of fibroblast growth factor
    Miao, JY
    Zhao, BX
    Li, HH
    Zhang, SL
    Du, CQ
    ACTA PHARMACOLOGICA SINICA, 2002, 23 (04) : 323 - 326
  • [3] Detection by the comet assay of apoptosis induced in lymphoid cell lines after growth factor deprivation
    Florent, M
    Godard, T
    Ballet, JJ
    Gauduchon, P
    Sola, B
    CELL BIOLOGY AND TOXICOLOGY, 1999, 15 (03) : 185 - 192
  • [4] Detection by the comet assay of apoptosis induced in lymphoid cell lines after growth factor deprivation
    M. Florent
    T. Godard
    J.J. Ballet
    P. Gauduchon
    B. Sola
    Cell Biology and Toxicology, 1999, 15 : 185 - 192
  • [5] Nerve growth factor-dependent regulation of NADE-induced apoptosis
    Muka, J
    Suvant, P
    Sato, TA
    VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 66, 2003, 66 : 385 - 402
  • [6] CHOP is involved in neuronal apoptosis induced by neurotrophic factor deprivation
    Tajiri, Seiji
    Yano, Shigetoshi
    Morioka, Motohiro
    Kuratsu, Jun-ichi
    Mori, Masataka
    Gotoh, Tomomi
    FEBS LETTERS, 2006, 580 (14) : 3462 - 3468
  • [7] Characterization of c-myc-transformed rat fibroblasts resistant to apoptosis induced by growth factor deprivation
    Dhanaraj, SN
    Marcus, AM
    Korah, RM
    Iwata, K
    Small, MB
    EXPERIMENTAL CELL RESEARCH, 1996, 224 (01) : 52 - 62
  • [8] Transforming growth factor β1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages
    Chin, BY
    Petrache, I
    Choi, AMK
    Choi, ME
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) : 11362 - 11368
  • [9] Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway
    Bruno Cenni
    Stefan Aebi
    Alissar Nehmé
    Randolph D. Christen
    Cancer Chemotherapy and Pharmacology, 2001, 47 : 397 - 403
  • [10] Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway
    Cenni, B
    Aebi, S
    Nehmé, A
    Christen, RD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (05) : 397 - 403